US$13.4 million backlog supports Amaero’s US$16.0 million revenue outlook

Revenue growth collides with a going-concern warning

Amaero Inc. (NASDAQ:AMRO; ASX:3DA) has delivered the sort of growth its newly expanded manufacturing base was built to produce, but not yet the economics needed to support it. Revenue reached US$11.5 million for the nine months to 30 September 2026, up 170% from US$4.3 million a year earlier, while the net loss attributable to shareholders widened 75% to US$22.5 million.

The warning in the accounts is unusually direct: management says substantial doubt exists about Amaero’s ability to continue as a going concern within one year of the accounts being issued. That conclusion remains in place even after the company raised US$17.0 million net through its October Nasdaq initial public offering and released US$2.1 million of restricted cash under an amended Export-Import Bank facility.

Backlog and defence contracts improve revenue visibility

Amaero’s backlog stood at US$13.4 million at 30 September, almost double the US$6.9 million recorded at the end of 2025 and 180% above the year-earlier figure. The total includes US$4.4 million tied to a US$4.5 million Department of War programme to develop alternative refractory alloy powders, awarded in July and scheduled to run through August 2027. The programme was part of the earlier Department of War contract coverage, which reported the award as a major expansion of Amaero’s defence-oriented materials strategy.

PM-HIP components also began moving beyond qualification work and into production. Revenue from that division rose 146% year on year to US$0.9 million in the third quarter, including the first revenue recognised under a US$0.3 million low-rate initial production contract with Bechtel Plant Machinery for the US submarine industrial base. Metal powders remained the larger business, generating US$3.2 million in the quarter and US$9.4 million over nine months.

Production disruption leaves margins deeply negative

The revenue gains came with a sharp deterioration in manufacturing economics. Third-quarter cost of revenue climbed 170% to US$8.5 million against revenue of US$4.1 million, producing a gross loss of US$4.4 million compared with a US$0.1 million loss in the prior-year quarter. Net loss more than doubled to US$9.1 million, or US$0.38 a share, while Adjusted EBITDA fell to negative US$7.1 million.

Amaero attributed the pressure to the restart of titanium production after a six-week pause, lower yields during the optimisation of a new sieving system and fixed production costs that were not absorbed because output remained below installed capacity. The pause followed safety incidents at the Tennessee facility, an episode covered in the titanium production restart report. The company says production resumed in late July after a review with Jensen Hughes, with no purchase-order cancellations or employee attrition during the interruption.

IPO extends the runway but does not solve the funding gap

Amaero ended September with US$5.0 million in cash and US$4.7 million in restricted cash, after using US$19.2 million in operating activities and US$13.9 million on property, plant and equipment during the first nine months. Gross debt under the EXIM facility stood at US$26.1 million, while the borrowing capacity was fully drawn in July.

The October IPO and loan amendment improved the immediate cash position: cash and cash equivalents were US$19.3 million at 31 October, after the company received the IPO proceeds and the restricted-cash release. But Amaero says those resources are expected to fund operations and capital expenditure only into the second quarter of 2027. Remaining commitments include US$5.7 million of contracted capital equipment spending, including the fourth EIGA atomizer and argon recycling system, plus US$6.4 million of inventory purchase commitments.

Guidance depends on capacity and yield recovery

Amaero guided to fourth-quarter revenue of US$4.5 million to US$5.0 million, implying full-year revenue of US$16.0 million to US$16.5 million, or growth of 154% to 162% from 2025. The company expects its fixed production base to support better operating leverage as titanium output and yields improve, with argon recycling targeted for commissioning in the first quarter of 2027 and a fourth EIGA atomizer scheduled for June 2027.

That forecast creates a clear test for the next phase of the story. The commercial signals are strengthening, but the business must convert backlog into cash-generating production before its capital requirements outrun the Nasdaq-funded runway. The next quarterly result will show whether the expanded plant is beginning to absorb its fixed costs, or simply making the funding question more urgent.